Hisamitsu Pharmaceutical Net Income vs. Total Debt

HPX Stock  EUR 24.80  0.00  0.00%   
Taking into consideration Hisamitsu Pharmaceutical's profitability measurements, Hisamitsu Pharmaceutical Co may not be well positioned to generate adequate gross income at the moment. It has a very high risk of underperforming in January. Profitability indicators assess Hisamitsu Pharmaceutical's ability to earn profits and add value for shareholders.
For Hisamitsu Pharmaceutical profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Hisamitsu Pharmaceutical to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Hisamitsu Pharmaceutical Co utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Hisamitsu Pharmaceutical's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Hisamitsu Pharmaceutical Co over time as well as its relative position and ranking within its peers.
  
Check out Risk vs Return Analysis.
Please note, there is a significant difference between Hisamitsu Pharmaceutical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Hisamitsu Pharmaceutical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Hisamitsu Pharmaceutical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Hisamitsu Pharmaceutical Total Debt vs. Net Income Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Hisamitsu Pharmaceutical's current stock value. Our valuation model uses many indicators to compare Hisamitsu Pharmaceutical value to that of its competitors to determine the firm's financial worth.
Hisamitsu Pharmaceutical Co is one of the top stocks in net income category among its peers. It also is rated as one of the top companies in total debt category among its peers making up about  0.02  of Total Debt per Net Income. The ratio of Net Income to Total Debt for Hisamitsu Pharmaceutical Co is roughly  44.10 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Hisamitsu Pharmaceutical's earnings, one of the primary drivers of an investment's value.

Hisamitsu Total Debt vs. Net Income

Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.

Hisamitsu Pharmaceutical

Net Income

 = 

(Rev + Gain)

-

(Exp + Loss)

 = 
9.66 B
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.

Hisamitsu Pharmaceutical

Total Debt

 = 

Bonds

+

Notes

 = 
219 M
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.

Hisamitsu Total Debt vs Competition

Hisamitsu Pharmaceutical Co is rated as one of the top companies in total debt category among its peers. Total debt of Drug Manufacturers—Specialty & Generic industry is currently estimated at about 7.53 Billion. Hisamitsu Pharmaceutical holds roughly 219 Million in total debt claiming about 2.91% of equities under Drug Manufacturers—Specialty & Generic industry.
Total debt  Revenue  Workforce  Capitalization  Valuation

Hisamitsu Pharmaceutical Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Hisamitsu Pharmaceutical, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Hisamitsu Pharmaceutical will eventually generate negative long term returns. The profitability progress is the general direction of Hisamitsu Pharmaceutical's change in net profit over the period of time. It can combine multiple indicators of Hisamitsu Pharmaceutical, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Hisamitsu Pharmaceutical Co., Inc. engages in the research and development, manufacture, purchase, and sale of pharmaceuticals in Japan. Hisamitsu Pharmaceutical Co., Inc. was founded in 1847 and is headquartered in Tosu, Japan. HISAMITSU PHARMA operates under Drug ManufacturersSpecialty Generic classification in Germany and is traded on Frankfurt Stock Exchange. It employs 2770 people.

Hisamitsu Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Hisamitsu Pharmaceutical. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Hisamitsu Pharmaceutical position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Hisamitsu Pharmaceutical's important profitability drivers and their relationship over time.

Use Hisamitsu Pharmaceutical in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Hisamitsu Pharmaceutical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Hisamitsu Pharmaceutical will appreciate offsetting losses from the drop in the long position's value.

Hisamitsu Pharmaceutical Pair Trading

Hisamitsu Pharmaceutical Co Pair Trading Analysis

The ability to find closely correlated positions to Hisamitsu Pharmaceutical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Hisamitsu Pharmaceutical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Hisamitsu Pharmaceutical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Hisamitsu Pharmaceutical Co to buy it.
The correlation of Hisamitsu Pharmaceutical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Hisamitsu Pharmaceutical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Hisamitsu Pharmaceutical moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Hisamitsu Pharmaceutical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Hisamitsu Pharmaceutical position

In addition to having Hisamitsu Pharmaceutical in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Soft Drinks Thematic Idea Now

Soft Drinks
Soft Drinks Theme
Entities manufacturing and distributing non alcoholic beverages across different markets. The Soft Drinks theme has 48 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Soft Drinks Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in Hisamitsu Stock

To fully project Hisamitsu Pharmaceutical's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Hisamitsu Pharmaceutical at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Hisamitsu Pharmaceutical's income statement, its balance sheet, and the statement of cash flows.
Potential Hisamitsu Pharmaceutical investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Hisamitsu Pharmaceutical investors may work on each financial statement separately, they are all related. The changes in Hisamitsu Pharmaceutical's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Hisamitsu Pharmaceutical's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.